WHO Issues Guidelines for Expanding Access to Hearing Aids 01/03/2024 Zuzanna Stawiska Over 400 million people with hearing loss could benefit from hearing devices. However, less than 20% of those people actually get hearing aids. That’s one of the findings cited in new World Health Organisation guidelines on improving access to hearing care, published Friday, just ahead of World Hearing Day. “Unaddressed hearing loss is a global […] Continue reading -> Cutting the Ribbon Virtually for a WHO Global Digital Health Initiative 22/02/2024 Zuzanna Stawiska “In a digital age, health workers should not have to carry a separate device for each disease or be required to fill out both paper and electronic records,” said WHO Director Dr Tedros Adhanom Ghebreyesus on Tuesday. He was speaking at WHO’s launch of the Global Initiative on Digital Health – where officials cut a […] Continue reading -> Shortage of Cholera Vaccines Spurs Africa CDC’s Quest for Local Manufacturing of Medical Products 20/02/2024 Kerry Cullinan The Democratic Republic of Congo (DRC) needs at least five million cholera vaccines to address the worst outbreak of the disease on the African continent – but it has received none so far. Meanwhile, Zambia has received half the cholera vaccines it needs and less than a third of Zimbabwe’s vaccine needs have been met, […] Continue reading -> Africa CDC Announces Pooled Medicines Procurement at AU Summit; Leaders Called Upon To Expedite African Medicines Agency Set-Up 19/02/2024 Elaine Ruth Fletcher The Africa Centres for Disease Control and Prevention (Africa CDC), has announced the creation of a pooled African medicines procurement mechanism at the 37th African Union Summit, which ended yesterday. The mechanism aims to spearhead “a new era of predictable demand for African manufacturers, empowering them to plan for the long-term and establish a robust […] Continue reading -> From Pandemics to AI: Unpacking the Forces Shaping Global Health Policies 17/02/2024 Maayan Hoffman In the most recent episodes of the Global Health Matters podcast, host Dr Garry Aslanyan and his guests reflect on the forces and factors that shape the economic, social, and physical landscape affecting health for all. “The global policy landscape is changing more rapidly than ever due to the influence of pandemics, regional conflicts and […] Continue reading -> India Pushes Back To Protect Patient Access to Generic Medicines 15/02/2024 Disha Shetty PUNE, INDIA – Commerce minister Sunil Barthwal has clarified that India will not sign a new trade agreement with the European Free Trade Association (EFTA) that would limit access by the country’s thriving generic medicine industry to new drug formulations for critical diseases. India is currently negotiating a new trade deal with the EFTA, which […] Continue reading -> Without Ensuring Swift Access to Pathogens, Pandemic Accord Risks Failure 13/02/2024 Thomas B. Cueni A wide array of stakeholders are looking toward the upcoming World Health Assembly this May to conclude negotiations on a new pandemic accord that seeks to make the world more prepared for the next pandemic. And most would agree that the primary task of the Intergovernmental Negotiating Body (INB), established by the World Health Assembly […] Continue reading -> Evergreening of Medicine Patents is ‘Abuse’ of Intellectual Property System 08/02/2024 Kerry Cullinan Evergreening patents on medical products – extending the lifespan of patents that are about to expire – is an “abuse of the intellectual property system”, an HIV activist told the World Health Organization’s (WHO) Fair Pricing Forum on Thursday. Meanwhile, an industry representative laid out her company’s value-based, country-specific approach to improving access to medicines, […] Continue reading -> Forum Discusses High Drug Prices in Wealthy Countries and Access to Medicines in Conflicts 07/02/2024 Kerry Cullinan The high price of medicines in many high- and middle-income countries and ensuring medical supply chains during crises were some of the issues discussed at the Fair Pricing Forum, which opened on Monday. The three-day forum, hosted by the World Health Organization’s (WHO), brings member states and stakeholders together to discuss how to ensure “optimal access […] Continue reading -> The Campaign to Recognize Noma as an NTD: How Inclusion Can Drive Research to Prevent and Treat the Disease 31/01/2024 Maayan Hoffman A milestone World Health Organization (WHO) decision to recognise noma (cancrum oris or gangrenous stomatitis) as a neglected tropical disease (NTD) is the result of a longstanding campaign waged for over a decade by global health researchers and advocates in Geneva and beyond. Proponents believe that inclusion can offer noma’s victims the […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Cutting the Ribbon Virtually for a WHO Global Digital Health Initiative 22/02/2024 Zuzanna Stawiska “In a digital age, health workers should not have to carry a separate device for each disease or be required to fill out both paper and electronic records,” said WHO Director Dr Tedros Adhanom Ghebreyesus on Tuesday. He was speaking at WHO’s launch of the Global Initiative on Digital Health – where officials cut a […] Continue reading -> Shortage of Cholera Vaccines Spurs Africa CDC’s Quest for Local Manufacturing of Medical Products 20/02/2024 Kerry Cullinan The Democratic Republic of Congo (DRC) needs at least five million cholera vaccines to address the worst outbreak of the disease on the African continent – but it has received none so far. Meanwhile, Zambia has received half the cholera vaccines it needs and less than a third of Zimbabwe’s vaccine needs have been met, […] Continue reading -> Africa CDC Announces Pooled Medicines Procurement at AU Summit; Leaders Called Upon To Expedite African Medicines Agency Set-Up 19/02/2024 Elaine Ruth Fletcher The Africa Centres for Disease Control and Prevention (Africa CDC), has announced the creation of a pooled African medicines procurement mechanism at the 37th African Union Summit, which ended yesterday. The mechanism aims to spearhead “a new era of predictable demand for African manufacturers, empowering them to plan for the long-term and establish a robust […] Continue reading -> From Pandemics to AI: Unpacking the Forces Shaping Global Health Policies 17/02/2024 Maayan Hoffman In the most recent episodes of the Global Health Matters podcast, host Dr Garry Aslanyan and his guests reflect on the forces and factors that shape the economic, social, and physical landscape affecting health for all. “The global policy landscape is changing more rapidly than ever due to the influence of pandemics, regional conflicts and […] Continue reading -> India Pushes Back To Protect Patient Access to Generic Medicines 15/02/2024 Disha Shetty PUNE, INDIA – Commerce minister Sunil Barthwal has clarified that India will not sign a new trade agreement with the European Free Trade Association (EFTA) that would limit access by the country’s thriving generic medicine industry to new drug formulations for critical diseases. India is currently negotiating a new trade deal with the EFTA, which […] Continue reading -> Without Ensuring Swift Access to Pathogens, Pandemic Accord Risks Failure 13/02/2024 Thomas B. Cueni A wide array of stakeholders are looking toward the upcoming World Health Assembly this May to conclude negotiations on a new pandemic accord that seeks to make the world more prepared for the next pandemic. And most would agree that the primary task of the Intergovernmental Negotiating Body (INB), established by the World Health Assembly […] Continue reading -> Evergreening of Medicine Patents is ‘Abuse’ of Intellectual Property System 08/02/2024 Kerry Cullinan Evergreening patents on medical products – extending the lifespan of patents that are about to expire – is an “abuse of the intellectual property system”, an HIV activist told the World Health Organization’s (WHO) Fair Pricing Forum on Thursday. Meanwhile, an industry representative laid out her company’s value-based, country-specific approach to improving access to medicines, […] Continue reading -> Forum Discusses High Drug Prices in Wealthy Countries and Access to Medicines in Conflicts 07/02/2024 Kerry Cullinan The high price of medicines in many high- and middle-income countries and ensuring medical supply chains during crises were some of the issues discussed at the Fair Pricing Forum, which opened on Monday. The three-day forum, hosted by the World Health Organization’s (WHO), brings member states and stakeholders together to discuss how to ensure “optimal access […] Continue reading -> The Campaign to Recognize Noma as an NTD: How Inclusion Can Drive Research to Prevent and Treat the Disease 31/01/2024 Maayan Hoffman A milestone World Health Organization (WHO) decision to recognise noma (cancrum oris or gangrenous stomatitis) as a neglected tropical disease (NTD) is the result of a longstanding campaign waged for over a decade by global health researchers and advocates in Geneva and beyond. Proponents believe that inclusion can offer noma’s victims the […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Shortage of Cholera Vaccines Spurs Africa CDC’s Quest for Local Manufacturing of Medical Products 20/02/2024 Kerry Cullinan The Democratic Republic of Congo (DRC) needs at least five million cholera vaccines to address the worst outbreak of the disease on the African continent – but it has received none so far. Meanwhile, Zambia has received half the cholera vaccines it needs and less than a third of Zimbabwe’s vaccine needs have been met, […] Continue reading -> Africa CDC Announces Pooled Medicines Procurement at AU Summit; Leaders Called Upon To Expedite African Medicines Agency Set-Up 19/02/2024 Elaine Ruth Fletcher The Africa Centres for Disease Control and Prevention (Africa CDC), has announced the creation of a pooled African medicines procurement mechanism at the 37th African Union Summit, which ended yesterday. The mechanism aims to spearhead “a new era of predictable demand for African manufacturers, empowering them to plan for the long-term and establish a robust […] Continue reading -> From Pandemics to AI: Unpacking the Forces Shaping Global Health Policies 17/02/2024 Maayan Hoffman In the most recent episodes of the Global Health Matters podcast, host Dr Garry Aslanyan and his guests reflect on the forces and factors that shape the economic, social, and physical landscape affecting health for all. “The global policy landscape is changing more rapidly than ever due to the influence of pandemics, regional conflicts and […] Continue reading -> India Pushes Back To Protect Patient Access to Generic Medicines 15/02/2024 Disha Shetty PUNE, INDIA – Commerce minister Sunil Barthwal has clarified that India will not sign a new trade agreement with the European Free Trade Association (EFTA) that would limit access by the country’s thriving generic medicine industry to new drug formulations for critical diseases. India is currently negotiating a new trade deal with the EFTA, which […] Continue reading -> Without Ensuring Swift Access to Pathogens, Pandemic Accord Risks Failure 13/02/2024 Thomas B. Cueni A wide array of stakeholders are looking toward the upcoming World Health Assembly this May to conclude negotiations on a new pandemic accord that seeks to make the world more prepared for the next pandemic. And most would agree that the primary task of the Intergovernmental Negotiating Body (INB), established by the World Health Assembly […] Continue reading -> Evergreening of Medicine Patents is ‘Abuse’ of Intellectual Property System 08/02/2024 Kerry Cullinan Evergreening patents on medical products – extending the lifespan of patents that are about to expire – is an “abuse of the intellectual property system”, an HIV activist told the World Health Organization’s (WHO) Fair Pricing Forum on Thursday. Meanwhile, an industry representative laid out her company’s value-based, country-specific approach to improving access to medicines, […] Continue reading -> Forum Discusses High Drug Prices in Wealthy Countries and Access to Medicines in Conflicts 07/02/2024 Kerry Cullinan The high price of medicines in many high- and middle-income countries and ensuring medical supply chains during crises were some of the issues discussed at the Fair Pricing Forum, which opened on Monday. The three-day forum, hosted by the World Health Organization’s (WHO), brings member states and stakeholders together to discuss how to ensure “optimal access […] Continue reading -> The Campaign to Recognize Noma as an NTD: How Inclusion Can Drive Research to Prevent and Treat the Disease 31/01/2024 Maayan Hoffman A milestone World Health Organization (WHO) decision to recognise noma (cancrum oris or gangrenous stomatitis) as a neglected tropical disease (NTD) is the result of a longstanding campaign waged for over a decade by global health researchers and advocates in Geneva and beyond. Proponents believe that inclusion can offer noma’s victims the […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Africa CDC Announces Pooled Medicines Procurement at AU Summit; Leaders Called Upon To Expedite African Medicines Agency Set-Up 19/02/2024 Elaine Ruth Fletcher The Africa Centres for Disease Control and Prevention (Africa CDC), has announced the creation of a pooled African medicines procurement mechanism at the 37th African Union Summit, which ended yesterday. The mechanism aims to spearhead “a new era of predictable demand for African manufacturers, empowering them to plan for the long-term and establish a robust […] Continue reading -> From Pandemics to AI: Unpacking the Forces Shaping Global Health Policies 17/02/2024 Maayan Hoffman In the most recent episodes of the Global Health Matters podcast, host Dr Garry Aslanyan and his guests reflect on the forces and factors that shape the economic, social, and physical landscape affecting health for all. “The global policy landscape is changing more rapidly than ever due to the influence of pandemics, regional conflicts and […] Continue reading -> India Pushes Back To Protect Patient Access to Generic Medicines 15/02/2024 Disha Shetty PUNE, INDIA – Commerce minister Sunil Barthwal has clarified that India will not sign a new trade agreement with the European Free Trade Association (EFTA) that would limit access by the country’s thriving generic medicine industry to new drug formulations for critical diseases. India is currently negotiating a new trade deal with the EFTA, which […] Continue reading -> Without Ensuring Swift Access to Pathogens, Pandemic Accord Risks Failure 13/02/2024 Thomas B. Cueni A wide array of stakeholders are looking toward the upcoming World Health Assembly this May to conclude negotiations on a new pandemic accord that seeks to make the world more prepared for the next pandemic. And most would agree that the primary task of the Intergovernmental Negotiating Body (INB), established by the World Health Assembly […] Continue reading -> Evergreening of Medicine Patents is ‘Abuse’ of Intellectual Property System 08/02/2024 Kerry Cullinan Evergreening patents on medical products – extending the lifespan of patents that are about to expire – is an “abuse of the intellectual property system”, an HIV activist told the World Health Organization’s (WHO) Fair Pricing Forum on Thursday. Meanwhile, an industry representative laid out her company’s value-based, country-specific approach to improving access to medicines, […] Continue reading -> Forum Discusses High Drug Prices in Wealthy Countries and Access to Medicines in Conflicts 07/02/2024 Kerry Cullinan The high price of medicines in many high- and middle-income countries and ensuring medical supply chains during crises were some of the issues discussed at the Fair Pricing Forum, which opened on Monday. The three-day forum, hosted by the World Health Organization’s (WHO), brings member states and stakeholders together to discuss how to ensure “optimal access […] Continue reading -> The Campaign to Recognize Noma as an NTD: How Inclusion Can Drive Research to Prevent and Treat the Disease 31/01/2024 Maayan Hoffman A milestone World Health Organization (WHO) decision to recognise noma (cancrum oris or gangrenous stomatitis) as a neglected tropical disease (NTD) is the result of a longstanding campaign waged for over a decade by global health researchers and advocates in Geneva and beyond. Proponents believe that inclusion can offer noma’s victims the […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
From Pandemics to AI: Unpacking the Forces Shaping Global Health Policies 17/02/2024 Maayan Hoffman In the most recent episodes of the Global Health Matters podcast, host Dr Garry Aslanyan and his guests reflect on the forces and factors that shape the economic, social, and physical landscape affecting health for all. “The global policy landscape is changing more rapidly than ever due to the influence of pandemics, regional conflicts and […] Continue reading -> India Pushes Back To Protect Patient Access to Generic Medicines 15/02/2024 Disha Shetty PUNE, INDIA – Commerce minister Sunil Barthwal has clarified that India will not sign a new trade agreement with the European Free Trade Association (EFTA) that would limit access by the country’s thriving generic medicine industry to new drug formulations for critical diseases. India is currently negotiating a new trade deal with the EFTA, which […] Continue reading -> Without Ensuring Swift Access to Pathogens, Pandemic Accord Risks Failure 13/02/2024 Thomas B. Cueni A wide array of stakeholders are looking toward the upcoming World Health Assembly this May to conclude negotiations on a new pandemic accord that seeks to make the world more prepared for the next pandemic. And most would agree that the primary task of the Intergovernmental Negotiating Body (INB), established by the World Health Assembly […] Continue reading -> Evergreening of Medicine Patents is ‘Abuse’ of Intellectual Property System 08/02/2024 Kerry Cullinan Evergreening patents on medical products – extending the lifespan of patents that are about to expire – is an “abuse of the intellectual property system”, an HIV activist told the World Health Organization’s (WHO) Fair Pricing Forum on Thursday. Meanwhile, an industry representative laid out her company’s value-based, country-specific approach to improving access to medicines, […] Continue reading -> Forum Discusses High Drug Prices in Wealthy Countries and Access to Medicines in Conflicts 07/02/2024 Kerry Cullinan The high price of medicines in many high- and middle-income countries and ensuring medical supply chains during crises were some of the issues discussed at the Fair Pricing Forum, which opened on Monday. The three-day forum, hosted by the World Health Organization’s (WHO), brings member states and stakeholders together to discuss how to ensure “optimal access […] Continue reading -> The Campaign to Recognize Noma as an NTD: How Inclusion Can Drive Research to Prevent and Treat the Disease 31/01/2024 Maayan Hoffman A milestone World Health Organization (WHO) decision to recognise noma (cancrum oris or gangrenous stomatitis) as a neglected tropical disease (NTD) is the result of a longstanding campaign waged for over a decade by global health researchers and advocates in Geneva and beyond. Proponents believe that inclusion can offer noma’s victims the […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
India Pushes Back To Protect Patient Access to Generic Medicines 15/02/2024 Disha Shetty PUNE, INDIA – Commerce minister Sunil Barthwal has clarified that India will not sign a new trade agreement with the European Free Trade Association (EFTA) that would limit access by the country’s thriving generic medicine industry to new drug formulations for critical diseases. India is currently negotiating a new trade deal with the EFTA, which […] Continue reading -> Without Ensuring Swift Access to Pathogens, Pandemic Accord Risks Failure 13/02/2024 Thomas B. Cueni A wide array of stakeholders are looking toward the upcoming World Health Assembly this May to conclude negotiations on a new pandemic accord that seeks to make the world more prepared for the next pandemic. And most would agree that the primary task of the Intergovernmental Negotiating Body (INB), established by the World Health Assembly […] Continue reading -> Evergreening of Medicine Patents is ‘Abuse’ of Intellectual Property System 08/02/2024 Kerry Cullinan Evergreening patents on medical products – extending the lifespan of patents that are about to expire – is an “abuse of the intellectual property system”, an HIV activist told the World Health Organization’s (WHO) Fair Pricing Forum on Thursday. Meanwhile, an industry representative laid out her company’s value-based, country-specific approach to improving access to medicines, […] Continue reading -> Forum Discusses High Drug Prices in Wealthy Countries and Access to Medicines in Conflicts 07/02/2024 Kerry Cullinan The high price of medicines in many high- and middle-income countries and ensuring medical supply chains during crises were some of the issues discussed at the Fair Pricing Forum, which opened on Monday. The three-day forum, hosted by the World Health Organization’s (WHO), brings member states and stakeholders together to discuss how to ensure “optimal access […] Continue reading -> The Campaign to Recognize Noma as an NTD: How Inclusion Can Drive Research to Prevent and Treat the Disease 31/01/2024 Maayan Hoffman A milestone World Health Organization (WHO) decision to recognise noma (cancrum oris or gangrenous stomatitis) as a neglected tropical disease (NTD) is the result of a longstanding campaign waged for over a decade by global health researchers and advocates in Geneva and beyond. Proponents believe that inclusion can offer noma’s victims the […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Without Ensuring Swift Access to Pathogens, Pandemic Accord Risks Failure 13/02/2024 Thomas B. Cueni A wide array of stakeholders are looking toward the upcoming World Health Assembly this May to conclude negotiations on a new pandemic accord that seeks to make the world more prepared for the next pandemic. And most would agree that the primary task of the Intergovernmental Negotiating Body (INB), established by the World Health Assembly […] Continue reading -> Evergreening of Medicine Patents is ‘Abuse’ of Intellectual Property System 08/02/2024 Kerry Cullinan Evergreening patents on medical products – extending the lifespan of patents that are about to expire – is an “abuse of the intellectual property system”, an HIV activist told the World Health Organization’s (WHO) Fair Pricing Forum on Thursday. Meanwhile, an industry representative laid out her company’s value-based, country-specific approach to improving access to medicines, […] Continue reading -> Forum Discusses High Drug Prices in Wealthy Countries and Access to Medicines in Conflicts 07/02/2024 Kerry Cullinan The high price of medicines in many high- and middle-income countries and ensuring medical supply chains during crises were some of the issues discussed at the Fair Pricing Forum, which opened on Monday. The three-day forum, hosted by the World Health Organization’s (WHO), brings member states and stakeholders together to discuss how to ensure “optimal access […] Continue reading -> The Campaign to Recognize Noma as an NTD: How Inclusion Can Drive Research to Prevent and Treat the Disease 31/01/2024 Maayan Hoffman A milestone World Health Organization (WHO) decision to recognise noma (cancrum oris or gangrenous stomatitis) as a neglected tropical disease (NTD) is the result of a longstanding campaign waged for over a decade by global health researchers and advocates in Geneva and beyond. Proponents believe that inclusion can offer noma’s victims the […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Evergreening of Medicine Patents is ‘Abuse’ of Intellectual Property System 08/02/2024 Kerry Cullinan Evergreening patents on medical products – extending the lifespan of patents that are about to expire – is an “abuse of the intellectual property system”, an HIV activist told the World Health Organization’s (WHO) Fair Pricing Forum on Thursday. Meanwhile, an industry representative laid out her company’s value-based, country-specific approach to improving access to medicines, […] Continue reading -> Forum Discusses High Drug Prices in Wealthy Countries and Access to Medicines in Conflicts 07/02/2024 Kerry Cullinan The high price of medicines in many high- and middle-income countries and ensuring medical supply chains during crises were some of the issues discussed at the Fair Pricing Forum, which opened on Monday. The three-day forum, hosted by the World Health Organization’s (WHO), brings member states and stakeholders together to discuss how to ensure “optimal access […] Continue reading -> The Campaign to Recognize Noma as an NTD: How Inclusion Can Drive Research to Prevent and Treat the Disease 31/01/2024 Maayan Hoffman A milestone World Health Organization (WHO) decision to recognise noma (cancrum oris or gangrenous stomatitis) as a neglected tropical disease (NTD) is the result of a longstanding campaign waged for over a decade by global health researchers and advocates in Geneva and beyond. Proponents believe that inclusion can offer noma’s victims the […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Forum Discusses High Drug Prices in Wealthy Countries and Access to Medicines in Conflicts 07/02/2024 Kerry Cullinan The high price of medicines in many high- and middle-income countries and ensuring medical supply chains during crises were some of the issues discussed at the Fair Pricing Forum, which opened on Monday. The three-day forum, hosted by the World Health Organization’s (WHO), brings member states and stakeholders together to discuss how to ensure “optimal access […] Continue reading -> The Campaign to Recognize Noma as an NTD: How Inclusion Can Drive Research to Prevent and Treat the Disease 31/01/2024 Maayan Hoffman A milestone World Health Organization (WHO) decision to recognise noma (cancrum oris or gangrenous stomatitis) as a neglected tropical disease (NTD) is the result of a longstanding campaign waged for over a decade by global health researchers and advocates in Geneva and beyond. Proponents believe that inclusion can offer noma’s victims the […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
The Campaign to Recognize Noma as an NTD: How Inclusion Can Drive Research to Prevent and Treat the Disease 31/01/2024 Maayan Hoffman A milestone World Health Organization (WHO) decision to recognise noma (cancrum oris or gangrenous stomatitis) as a neglected tropical disease (NTD) is the result of a longstanding campaign waged for over a decade by global health researchers and advocates in Geneva and beyond. Proponents believe that inclusion can offer noma’s victims the […] Continue reading -> Posts navigation Older postsNewer posts